Retatrutide calculator
The biggest number printed on the barrel.
Keep it on your phone
Add DoseClear to your home screen. It opens like an app, with your last numbers ready, and works without signal.
In Safari, tap Share , then Add to Home Screen.
Divide the mg in the vial by the mL of water to get the strength, then divide the dose by the strength and multiply by 100 for units. Example: 10 mg of retatrutide with 2 mL of water is 5 mg/mL, so 2 mg is 0.4 mL, or 40 units on a U-100 syringe.
Every step is shown
Open "Show the maths" and you can check each line yourself, or show it to someone you trust.
We catch the common slips
Mixing up mg and mcg, or picking the wrong syringe, are the usual mistakes. We flag both before you draw.
Your numbers stay yours
No account, no sign-up. The maths runs in your browser, and we never ask your name.
Is retatrutide FDA approved?
Not approved As of 2026-10-07, retatrutide is not approved by the FDA for any use. It is an investigational medicine made by Eli Lilly and is in phase 3 trials (the TRIUMPH programme, for example NCT05929066). Lilly has also registered a pre-approval expanded access programme (NCT07629401).
Retatrutide sold outside a trial or Lilly's programme is not an approved product. Its strength and purity can't be checked from the label, which is one more reason to check your maths twice.
Doses studied in trials
In the published phase 2 trial, adults with obesity took retatrutide once a week for 48 weeks at one of these doses. Several groups started lower and stepped up. This is what was studied, not a recommendation.
| Trial group | Weekly dose |
|---|---|
| Low | 1 mg |
| Middle | 4 mg (two groups: started at 2 mg, or at 4 mg) |
| Higher | 8 mg (two groups: started at 2 mg, or at 4 mg) |
| Highest | 12 mg (started at 2 mg) |
How much water for a 10 mg vial?
Any amount works as long as you use the same number when you calculate. Here's what 2 mg looks like on a 1 mL syringe for common choices:
| Vial | Water | Strength | 2 mg is | Doses per vial |
|---|---|---|---|---|
| 10 mg | 1 mL | 10 mg/mL | 20 units (0.2 mL) | 5 |
| 10 mg | 2 mL | 5 mg/mL | 40 units (0.4 mL) | 5 |
| 10 mg | 3 mL | 3.33 mg/mL | 60 units (0.6 mL) | 5 |
Not mixed yet? The reconstitution calculator shows which water amounts land on a line.
Sources
- Jastreboff AM et al. Triple-hormone-receptor agonist retatrutide for obesity: a phase 2 trial. N Engl J Med 2023;389:514-526: nejm.org
- TRIUMPH-1 phase 3 trial record: clinicaltrials.gov
- Pre-approval expanded access of retatrutide: clinicaltrials.gov